SLNO - Soleno Therapeutics Inc Stock Price, Fair Value and News

48.43USD+1.48 (+3.15%)Market Closed

Market Summary

USD48.43+1.48

Market Closed

3.15%

SLNO Alerts

2 major insider sales recently.

SLNO Stock Price

View Fullscreen

SLNO RSI Chart

SLNO Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-31.1

Price/Sales (Trailing)

1.1K

EV/EBITDA

-156.67

Price/Free Cashflow

-53

SLNO Price/Sales (Trailing)

SLNO Profitability

Operating Margin

26.92%

EBT Margin

-816.18%

Return on Equity

-36.29%

Return on Assets

-30.82%

Free Cashflow Yield

-1.89%

SLNO Fundamentals

SLNO Revenue

Revenue (TTM)

1.5M

SLNO Earnings

Earnings (TTM)

-52.0M

Earnings Growth (Yr)

-156.08%

Earnings Growth (Qtr)

-89.43%

Breaking Down SLNO Revenue

Last 7 days

3.1%

Last 30 days

22.4%

Last 90 days

27.8%

Trailing 12 Months

919.6%

How does SLNO drawdown profile look like?

SLNO Financial Health

Current Ratio

11.23

SLNO Investor Care

Shares Dilution (1Y)

309.01%

Diluted EPS (TTM)

-2.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2017	0	0	0	0
2016	812.6K	1.0M	1.2M	1.5M
2015	2.3M	1.7M	1.0M	387.6K
2013	0	0	0	3.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

CEO	Dr. Anish Bhatnagar M.D.
WEBSITE	https://soleno.life
INDUSTRY	Biotechnology
EMPLOYEES	25

Soleno Therapeutics Inc Frequently Asked Questions

What is the ticker symbol for Soleno Therapeutics Inc? What does SLNO stand for in stocks?

SLNO is the stock ticker symbol of Soleno Therapeutics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Soleno Therapeutics Inc (SLNO)?

As of Fri Jul 26 2024, market cap of Soleno Therapeutics Inc is 1.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SLNO stock?

You can check SLNO's fair value in chart for subscribers.

Is Soleno Therapeutics Inc a good stock to buy?

The fair value guage provides a quick view whether SLNO is over valued or under valued. Whether Soleno Therapeutics Inc is cheap or expensive depends on the assumptions which impact Soleno Therapeutics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SLNO.

What is Soleno Therapeutics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, SLNO's PE ratio (Price to Earnings) is -31.1 and Price to Sales (PS) ratio is 1.1 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SLNO PE ratio will change depending on the future growth rate expectations of investors.